TR
Tessa Romero JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
24
Avg Return
Past Year
Past Year
17%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
63.6%
Neutral
27.3%
Negative
9.1%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $62 |
55%
upside
| 2 | -0.75% |
0
%
| 9 Jan ‘26 10 days ago |
|
|
|
Neutral
Maintained
| $25 |
8%
downside
| 2 | – |
–
| 6 Jan ‘26 12 days ago |
|
|
|
Overweight
Initiated
| $38 |
51%
upside
| 1 | +29% |
0
%
| 19 Dec ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $15 |
14%
upside
| 1 | -17% |
0
%
| 20 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $47 |
5%
upside
| 1 | +23% |
0
%
| 18 Nov ‘25 2 months ago |
|
|
|
Underweight
Downgraded
| $263 |
7,125%
upside
| 1 | -20% |
0
%
| 18 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $31 |
19%
upside
| 1 | +8.6% |
0
%
| 17 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $17 |
2%
upside
| 1 | – |
–
| 14 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $34 |
24%
upside
| 1 | +26% |
0
%
| 14 Nov ‘25 2 months ago |
|